Literature DB >> 215747

Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferase.

R G Pendleton, G Gessner, G Weiner, B Jenkins, J Sawyer, W Bondinell, A Intoccia.   

Abstract

SK&F 29661 is an effective, reversible inhibitor of both central nervous system and adrenal phenylethanolamine N-methyl-transferase in vitro; its Ki values in our standard assay systems were 6 X 10(-7) M (central nervous system) and 3 X 10(-7) M (adrenal), respectively. In vivo, the drug inhibited the conversion of [3H]norepinephrine to [3H]epinephrine in the rat adrenal gland and upon chronic administration decreased the endogenous adrenal epinephrine/norepinephrine ratio in both the rat and squirrel monkey. SK&F 29661 did not, however, reduce rat brain stem PNMT activity after systemic administration; subsequent radioautographic studies indicated that the compound did not enter the central nervous system, presumably because of its high polarity. This drug may be useful in defining the physiological importance of peripheral phenylethanolamine N-methyltransferase inhibition.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 215747

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Application of the Goldilocks effect to the design of potent and selective inhibitors of phenylethanolamine N-methyltransferase: balancing pKa and steric effects in the optimization of 3-methyl-1,2,3,4-tetrahydroisoquinoline inhibitors by beta-fluorination.

Authors:  Gary L Grunewald; Mitchell R Seim; Jian Lu; Mariam Makboul; Kevin R Criscione
Journal:  J Med Chem       Date:  2006-05-18       Impact factor: 7.446

2.  Transition-State Analogues of Phenylethanolamine N-Methyltransferase.

Authors:  Niusha Mahmoodi; Rajesh K Harijan; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2020-08-07       Impact factor: 15.419

3.  Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors.

Authors:  Gary L Grunewald; Mitchell R Seim; Rachel C Regier; Kevin R Criscione
Journal:  Bioorg Med Chem       Date:  2006-11-10       Impact factor: 3.641

4.  Studies on the long term effects of SK&F 29661 upon adrenal catecholamines.

Authors:  R G Pendleton; G Gessner; J Sawyer; L Hillegass; D A Miller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

5.  Regulation of episodic growth hormone secretion by the central epinephrine system. Studies in the chronically cannulated rat.

Authors:  L C Terry; W R Crowley; M D Johnson
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

6.  Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.

Authors:  Gary L Grunewald; Mitchell R Seim; Seema R Bhat; Marc E Wilson; Kevin R Criscione
Journal:  Bioorg Med Chem       Date:  2007-10-11       Impact factor: 3.641

7.  Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels.

Authors:  B Kennedy; T D Bigby; M G Ziegler
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  The Adrenal Medulla Modulates Mechanical Allodynia in a Rat Model of Neuropathic Pain.

Authors:  Marina Arribas-Blázquez; Luis Alcides Olivos-Oré; María Victoria Barahona; Aneta Wojnicz; Ricardo De Pascual; Mercedes Sánchez de la Muela; Antonio G García; Antonio R Artalejo
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.